ClinicalTrials.Veeva

Menu

Post COVID-19 REspiratory Mechanisms and the Efficacy of a Breathing Exercise Intervention for DYsregulated Breathing (REMEDY)

U

University of Nottingham

Status

Active, not recruiting

Conditions

COVID-19
Respiratory Disease

Treatments

Other: Breathing techniques over 12 sessions / 6 weeks inc yoga

Study type

Interventional

Funder types

Other

Identifiers

NCT05732571
Post COVID-19 REMEDY (Other Identifier)
22023

Details and patient eligibility

About

A pilot Study

To investigate the efficacy of a breathing intervention for improving persistent breathlessness due to dysregulated breathing following COVID-19 when compared to usual care.

Full description

Pilot RCT for upto 60 subjects across 2 arms

Intervention A 12 session/six week, twice a week online group-based intervention based on breathing techniques including yoga practice directed by a specialist. Each group will aim for between 3- 6 participants.

Each online session will be circa 40-50 minutes in length. This will include an Introduction and warm up; Breathing practice including yogic breathing and a final cool down and relaxation.

Sessions will run at set times to ensure efficient use of resources but will try to accommodate different time points periods of the day when patients might be functioning best.

Comparator A six week non-intervention (usual care) period will be recruited to, allowing a comparison to the intervention.

Primary co-outcomes

Change in

  • Breathlessness: Chronic Respiratory Disease Questionnaire-Dyspnoea domain (CRQ-D)
  • Functional measure: 5 repetition chair to stand (5RCTS)

Secondary measures include other measures of breathlessness, function, adherence and completion (see full text for detail).

Enrollment

40 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Either hospitalised or non-hospitalised with confirmed COVID-19 acute infection.
  • Received a comprehensive clinical respiratory assessment
  • Persisting (>12 weeks) self-reported breathlessness (on CRQ-D) following COVID-19 and confirmed dysregulated breathing (Nijmegen Questionnaire score NQ >23)
  • Age 18 - 80 years of age
  • Ability to give informed consent
  • Able to understand and speak English language

Exclusion criteria

  • Severe mood disturbance that limits engagement with the intervention and study outcomes
  • No access to online delivery and/or IT illiterate
  • Significant diagnosed Myalgic Encephalitis/Fibromyalgia/Chronic Fatigue Syndrome prior to developing COVID-19
  • Severe asthma or other chronic lung disease prior to COVID-19

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

Breathing Techniques Intervention
Active Comparator group
Description:
A 12 session/six week, twice a week online group-based intervention based on breathing techniques including yoga practice directed by a specialist. Each group will aim for between 3- 6 participants.
Treatment:
Other: Breathing techniques over 12 sessions / 6 weeks inc yoga
Usual Care
No Intervention group
Description:
A six week non-intervention (usual care) period will be recruited to, allowing a comparison to the intervention.

Trial contacts and locations

1

Loading...

Central trial contact

Charlotte Bolton; Theresa Harvey-Dunstan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems